WHO ICTRP trial
Does the use of fixed-extended-duration antibiotics improve patient outcomes…
ISRCTN72819021 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting
Key facts
| Trial ID | ISRCTN72819021 |
|---|---|
| Public title | Does the use of fixed-extended-duration antibiotics improve patient outcomes compared to standard antibiotic durations in patients with complicated intra-abdominal infection? |
| Scientific title | The EXTEND trial: Fixed-extended-duration antibiotics (28 days) compared to standard care antibiotic durations in adult patients with complicated intra-abdominal infection and their impact on treatment failure - a Phase III multicentre, open-label, two-arm, parallel-group, pragmatic, randomised… |
| Primary sponsor | University of Leeds |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | United Kingdom;England |
| Conditions | Complicated Intra-Abdominal Infection (cIAI) Infections and Infestations |
| Interventions | Randomisation process: Participants will be individually randomised 1:1 between 28-days antibiotics and standard care antibiotic duration using stratified block randomisation with randomly varying block sizes. Stratification will be by… |
| Registration date | Nov 23, 2021 |
| Target size | 1166 |
| Secondary IDs | Nil known;Nil known;HTA - NIHR131784, IRAS 302989 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: